Fintel Plc (AIM:FNTL)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 215.68M |
| Revenue (ttm) | 85.00M |
| Net Income (ttm) | 6.20M |
| Shares Out | 104.19M |
| EPS (ttm) | 0.06 |
| PE Ratio | 34.79 |
| Forward PE | 15.16 |
| Dividend | 0.04 (1.80%) |
| Ex-Dividend Date | Sep 25, 2025 |
| Volume | 37,047 |
| Average Volume | 157,331 |
| Open | 209.00 |
| Previous Close | 208.00 |
| Day's Range | 207.00 - 221.00 |
| 52-Week Range | 204.50 - 297.00 |
| Beta | 0.52 |
| RSI | 40.10 |
| Earnings Date | Dec 17, 2025 |
About Fintel
Fintel Plc engages in the provision of intermediary services and distribution channels to the retail financial services sector in the United Kingdom. It operates through three segments: Intermediary Services, Distribution Channels, and Fintech and Research. The Intermediary Services segment provides compliance and regulation services to individual financial intermediary member firms, including directly authorized IFAs, mortgage advisers, and wealth managers, as well as workplace consultants. The Distribution Channels segment offers data, distri... [Read more]
Financial Performance
In 2024, Fintel's revenue was 78.30 million, an increase of 20.65% compared to the previous year's 64.90 million. Earnings were 5.90 million, a decrease of -16.90%.
Financial StatementsNews
CIBC Upgrades Canadian National Railway (CNI)
Fintel reports that on November 28, 2025, CIBC upgraded their outlook for Canadian National Railway (NYSE:CNI) from Neutral to Outperformer. Analyst Price Forecast Suggests 18.45% Upside
HC Wainwright & Co. Reiterates Halozyme Therapeutics (HALO) Buy Recommendation
Fintel reports that on November 28, 2025, HC Wainwright & Co. reiterated coverage of Halozyme Therapeutics (NasdaqGS:HALO) with a Buy recommendation. Analyst Price Forecast Suggests 6.50% Upside
HC Wainwright & Co. Reiterates Anavex Life Sciences (AVXL) Buy Recommendation
Fintel reports that on November 28, 2025, HC Wainwright & Co. reiterated coverage of Anavex Life Sciences (NasdaqGS:AVXL) with a Buy recommendation. Analyst Price Forecast Suggests 778.85% Upside
Keybanc Maintains NVIDIA (NVDA) Overweight Recommendation
Fintel reports that on November 20, 2025, Keybanc maintained coverage of NVIDIA (NasdaqGS:NVDA) with a Overweight recommendation. Analyst Price Forecast Suggests 27.06% Upside
Cantor Fitzgerald Reiterates NVIDIA (NVDA) Overweight Recommendation
Fintel reports that on November 20, 2025, Cantor Fitzgerald reiterated coverage of NVIDIA (NasdaqGS:NVDA) with a Overweight recommendation. Analyst Price Forecast Suggests 27.06% Upside
Wedbush Maintains NVIDIA (NVDA) Outperform Recommendation
Fintel reports that on November 20, 2025, Wedbush maintained coverage of NVIDIA (NasdaqGS:NVDA) with a Outperform recommendation. Analyst Price Forecast Suggests 27.06% Upside
Argus Research Reiterates NVIDIA (NVDA) Buy Recommendation
Fintel reports that on November 20, 2025, Argus Research reiterated coverage of NVIDIA (NasdaqGS:NVDA) with a Buy recommendation. Analyst Price Forecast Suggests 27.06% Upside
Baird Maintains NVIDIA (NVDA) Outperform Recommendation
Fintel reports that on November 20, 2025, Baird maintained coverage of NVIDIA (NasdaqGS:NVDA) with a Outperform recommendation. Analyst Price Forecast Suggests 27.06% Upside
DA Davidson Maintains NVIDIA (NVDA) Buy Recommendation
Fintel reports that on November 20, 2025, DA Davidson maintained coverage of NVIDIA (NasdaqGS:NVDA) with a Buy recommendation. Analyst Price Forecast Suggests 27.06% Upside
Barclays Maintains NVIDIA (NVDA) Overweight Recommendation
Fintel reports that on November 20, 2025, Barclays maintained coverage of NVIDIA (NasdaqGS:NVDA) with a Overweight recommendation. Analyst Price Forecast Suggests 27.06% Upside
Stifel Maintains NVIDIA (NVDA) Buy Recommendation
Fintel reports that on November 18, 2025, Stifel maintained coverage of NVIDIA (NasdaqGS:NVDA) with a Buy recommendation. Analyst Price Forecast Suggests 27.00% Upside
Collapse Or Comeback? Key Takeaways From WeWork's Bankruptcy Restructuring
Key Takeaways WeWork Inc. filed for bankruptcy late in 2023. The company has negotiated substantial cost reductions in rent-commitment cuts and roughly $4 billion of debt has been eliminated. This mea...
JP Morgan Cazenove Reiterates Man Group (MNGPF) Neutral Recommendation
Fintel reports that on November 14, 2025, JP Morgan Cazenove reiterated coverage of Man Group (OTCPK:MNGPF) with a Neutral recommendation. Analyst Price Forecast Suggests 7.59% Downside
Deutsche Reiterates 3i Group (TGOPF) Buy Recommendation
Fintel reports that on November 13, 2025, Deutsche reiterated coverage of 3i Group (OTCPK:TGOPF) with a Buy recommendation. Analyst Price Forecast Suggests 65.87% Upside
Citigroup Reiterates 3i Group (TGOPF) Buy Recommendation
Fintel reports that on November 14, 2025, Citigroup reiterated coverage of 3i Group (OTCPK:TGOPF) with a Buy recommendation. Analyst Price Forecast Suggests 65.87% Upside
Berenberg Bank Reiterates QinetiQ Group (QNTQF) Buy Recommendation
Fintel reports that on November 14, 2025, Berenberg Bank reiterated coverage of QinetiQ Group (OTCPK:QNTQF) with a Buy recommendation. Analyst Price Forecast Suggests 28.95% Upside
JP Morgan Cazenove Reiterates Trainline (TNLIF) Neutral Recommendation
Fintel reports that on November 14, 2025, JP Morgan Cazenove reiterated coverage of Trainline (OTCPK:TNLIF) with a Neutral recommendation. What is the Fund Sentiment?
Deutsche Reiterates Burberry Group (BBRYF) Buy Recommendation
Fintel reports that on November 13, 2025, Deutsche reiterated coverage of Burberry Group (OTCPK:BBRYF) with a Buy recommendation. Analyst Price Forecast Suggests 32.80% Upside
Jefferies Reiterates Volex (VLXGF) Buy Recommendation
Fintel reports that on November 13, 2025, Jefferies reiterated coverage of Volex (OTCPK:VLXGF) with a Buy recommendation. Analyst Price Forecast Suggests 25.42% Upside
Peel Hunt Limited Reiterates Premier Foods (PFODF) Buy Recommendation
Fintel reports that on November 13, 2025, Peel Hunt Limited reiterated coverage of Premier Foods (OTCPK:PFODF) with a Buy recommendation. Analyst Price Forecast Suggests 38.01% Upside
Wells Fargo Maintains NVIDIA (NVDA) Overweight Recommendation
Fintel reports that on November 14, 2025, Wells Fargo maintained coverage of NVIDIA (NasdaqGS:NVDA) with a Overweight recommendation. Analyst Price Forecast Suggests 18.44% Upside
Keybanc Reiterates NVIDIA (NVDA) Overweight Recommendation
Fintel reports that on November 14, 2025, Keybanc reiterated coverage of NVIDIA (NasdaqGS:NVDA) with a Overweight recommendation. Analyst Price Forecast Suggests 18.44% Upside
Morgan Stanley Maintains NVIDIA (NVDA) Overweight Recommendation
Fintel reports that on November 14, 2025, Morgan Stanley maintained coverage of NVIDIA (NasdaqGS:NVDA) with a Overweight recommendation. Analyst Price Forecast Suggests 20.61% Upside
Oppenheimer Maintains NVIDIA (NVDA) Outperform Recommendation
Fintel reports that on November 13, 2025, Oppenheimer maintained coverage of NVIDIA (NasdaqGS:NVDA) with a Outperform recommendation. Analyst Price Forecast Suggests 16.29% Upside
Susquehanna Maintains NVIDIA (NVDA) Positive Recommendation
Fintel reports that on November 13, 2025, Susquehanna maintained coverage of NVIDIA (NasdaqGS:NVDA) with a Positive recommendation. Analyst Price Forecast Suggests 16.29% Upside